KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Gross Margin (2016 - 2025)

Historic Gross Margin for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to 29.84%.

  • Medpace Holdings' Gross Margin fell 18500.0% to 29.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.11%, marking a year-over-year increase of 14200.0%. This contributed to the annual value of 31.12% for FY2024, which is 33100.0% up from last year.
  • Latest data reveals that Medpace Holdings reported Gross Margin of 29.84% as of Q3 2025, which was down 18500.0% from 29.84% recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Gross Margin ranged from a high of 33.23% in Q4 2024 and a low of 26.82% during Q2 2021
  • For the 5-year period, Medpace Holdings' Gross Margin averaged around 29.52%, with its median value being 29.82% (2022).
  • Per our database at Business Quant, Medpace Holdings' Gross Margin plummeted by -39700bps in 2023 and then surged by 57800bps in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' Gross Margin stood at 28.52% in 2021, then rose by 3bps to 29.37% in 2022, then decreased by -7bps to 27.45% in 2023, then grew by 21bps to 33.23% in 2024, then fell by -10bps to 29.84% in 2025.
  • Its last three reported values are 29.84% in Q3 2025, 29.84% for Q2 2025, and 31.93% during Q1 2025.